Cellular and mitochondrial effects of alcohol consumption

International Journal of Environmental Research and Public Health

Volumn 7, Issue 12, 2010, Pages 4281-4304

  Manzo Avalos, Salvador ^a   Saavedra Molina, Alfredo ^a  

^a UNIVERSIDAD MICHOACANA DE SAN NICOLÁS DE HIDALGO   (Mexico)

Author keywords

Alcohol consumption; Antioxida; Mitochondria; Oxidative stress

Indexed keywords

PICEATANNOL; RESVERATROL;

ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ALCOHOL METABOLISM; ALCOHOLIC CARDIOMYOPATHY; CELL FUNCTION; DRINKING BEHAVIOR; FETAL ALCOHOL SYNDROME; HUMAN; LIPID PEROXIDATION; MITOCHONDRIAL RESPIRATION; NERVE DEGENERATION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PATHOGENESIS; REVIEW; STOMACH MUCOSA INJURY;

EID: 78650909074     PISSN: None     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph7124281     Document Type: Review

References (170)

1. Guo, R.; Ren, J. Alcohol and acetaldehyde in public health: From marvel to menace. Int. J. Environ. Res. Public Health 2010, 7, 1285-1301.
2. Mokdad, A.H.; Marks, J.S.; Stroup, D.F.; Gerberding, J.L. Actual causes of death in the United States. JAMA 2000, 291, 1238-1245.
3. Diagnostic and Statistical Manual of Mental Disorders, 4th ed.; American Psychiatric Association: Washington, DC, USA, 1994.
4. Grant, B.F.; Stinson, F.S.; Harford, T.C. Age at onset of alcohol use and DSM-IV alcohol abuse and dependence: A 12-year follow-up. J. Substain. Abuse. 2001, 13, 493-504.
5. George, A.; Figueredo, V.M. Alcohol and arrhythmias: A comprehensive review. J. Cardiov. Med. (Hagerstown) 2010, 11, 221-228.
6. Marinho, V.; Laks, J.; Engelhardt, E.; Conn, D. Alcohol abuse in an elderly woman taking donepezil for Alzheimer disease. J. Clin. Psychopharmacol. 2006, 26, 683-685
7. Ohkubo, T.; Metoki, H.; Imai, Y. Alcohol intake, circadian blood pressure variation, and stroke. Hypertension 2009, 53, 4-5.
8. Cederbaum, A.I.; Lu, Y.; Wu, D. Role of oxidative stress in alcohol-induced liver injury. Arch. Toxicol. 2009, 83, 519-548.
9. Seitz, H.K.; Becker, P. Alcohol metabolism and cancer risk. Alcohol Res. Health 2007, 30, 38-47.
10. Morris, M.J. Alcohol breath testing in patients with respiratory disease. Thorax 1990, 45, 717-721.
11. Baliunas, D.O.; Taylor, B.J.; Irving, H.; Roerecke, M.; Patra, J.; Mohapatra, S.; Rehm, J. Alcohol as a risk factor for type 2 diabetes: A systematic review and meta-analysis. Diabetes Care 2009, 32, 2123-2132.
12. Chen, Y.; Cui, L.; Liao, J.; huang, L. Effects of alcohol on bone metabolism and biomechanical property of mice. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2009, 26, 780-782.
13. Rehm, J.; Mathers, C.; Popova, S.; Thavorncharoensap, M.; Teerawattananon, Y.; Patra, J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet 2009, 373, 2223-2233.
14. Gohlke, J.M.; Griffith, W.C.; Faustman, E.M. Computational models of ethanol-induced neurodevelopmental toxicity across species: Implications for risk assessment. Birth Defects Res. B. Dev. Reprod. Toxicol. 2008, 83, 1-11.
15. Pietrzykowski, A.Z.; Friesen, R.M.; Martin, G.E.; Puig, S.I.; Nowak, C.L.; Wynne, P.M.; Siegelmann, H.T.; Treistman, S.N. Posttranscriptional regulation of BK channel splice variant stability by miR-9 underlies neuroadaptation to alcohol. Neuron 2008, 59, 274-287.
16. Roberto, M.; Treistman, S.N.; Pietrzykowski, A.Z.; Weiner, J.; Galindo, R.; Mameli, M.; Valenzuela, F.; Zhu, P.J.; Lovinger, D.; Zhang, T.A.; Hendricson, A.H.; Morrisett, R.; Siggins, G.R. Actions of acute and chronic ethanol on presynaptic terminals. Alcohol Clin. Exp. Res. 2006, 30, 222-232.
17. Wilkie, M.B.; Besheer, J.; Kelley, S.P.; Kumar, S.; O'Buckley, T.K.; Morrow, A.L.; Hodge, C.W. Acute ethanol administration rapidly increases phosphorylation of conventional protein kinase C in specific mammalian brain regions in vivo. Alcohol Clin. Exp. Res. 2007, 31, 1259-1267.
18. Le Marquand, D.; Pihl, R.O.; Benkelfat, C. Serotonin and alcohol intake, abuse, and dependence: Clinical evidence. Biol. Psychiatry 1994, 36, 326-337.
19. Prosser, R.A.; Mangrum, C.A.; Glass, J.D. Acute ethanol modulates glutamatergic and serotonergic phase shifts of the mouse circadian clock in vitro. Neuroscience 2008, 152, 837-848.
20. Wallner, M.; Hanchar, H.J.; Olsen, R.W. Low-dose alcohol actions on alpha4beta3delta GABAA receptors are reversed by the behavioral alcohol antagonist Ro15-4513. Proc. Natl. Acad. Sci. USA 2006, 103, 8540-8545.
21. Perra, S.; Pillolla, G.; Luchicchi, A.; Pistis, M. Alcohol inhibits spontaneous activity of basolateral amigdala proyection neurons in the rat: Involvement of the endocannabinoid system. Alcohol Clin. Exp. Res. 2008, 32, 443-449.
22. Fisher, S.J.; Lee, I.J.; Swaan, P.W.; Eddington, N.D. Evaluation of the effect of ethanol's toxic metabolite acetaldehyde on the gastrointestinal oligopeptide transporter, PEPT1: In vitro and in vivo studies. Alcohol Clin. Exp. Res. 2008, 32, 162-170.
23. Karinch, A.M.; Martin, J.H.; Vary, T.C. Acute and chronic ethanol consumption differentially impact pathways limiting hepatic protein synthesis. Am. J. Physiol. Endocrinol. Metab. 2008, 295, E3-E9.
24. Yang, A.L.; Vadhavkar, S.; Singh, G.; Omary, M.B. Epidemiology of alcohol-related liver and pancreatic disease in the United States. Arch. Intern. Med. 2008, 168, 649-656.
25. Ting, J.W.; Lautt, W.W. The effect of acute, chronic, and prenatal ethanol exposure on insulin sensitivity. Pharmacol. Ther. 2006, 111, 346-373.
26. Happel, K.I.; Rudner, X.; Quinton, L.J.; Movasshaghi, J.L.; Clark, C.; Odden, A.R.; Zhang, P.; Bagby, G.J.; Nelson, S.; Shellito, J.E. Acute alcohol intoxication suppresses the pulmonary ELR-negative CXC chemokine response to lipopolysaccharide. Alcohol 2007, 41, 325-333.
27. Greiffensstein, P.; Mathis, K.W.; Stouwe, C.V.; Molina, P.E. Alcohol binge before trauma/hemorrhage impairs integrity of host defense mechanisms during recovery. Alcohol Clin. Exp. Res. 2007, 31, 704-715.
28. Choudhry, M.A.; Li, X.; Chaudry, I.H. A role for corticosterone in impaired intestinal immunity and barrier function in a rodent model of acute alcohol intoxication and burn injury. J. Neuroimmune Pharmacol. 2006, 1, 428-434.
29. Radek, K.A.; Kovacs, E.J.; DiPietro, L.A. Matrix proteolytic activity during wound healing: Modulation by acute ethanol exposure. Alcohol Clin. Exp. Res. 2007, 31, 1045-1052.
30. Dolganiuc, A.; Szabo, G. In vitro and in vivo models of acute alcohol exposure. World J. Gastroenterol. 2009, 15, 1168-1177.
31. Werner, D.F.; Swihart, A.R.; Ferguson, C.; Lariviere, W.R.; Harrison, N.L.; Homanics, G.E. Alcohol-induced tolerance and physical dependence in mice with ethanol insensitive α1 GABAA receptors. Alcohol Clin. Exp. Res. 2009, 33, 289-299.
32. Norberg, A.; Jones, A.W.; Hahn, R.G.; Gabrielsson, J.L. Role of variability in explaining ethanol pharmacokinetics: Research and forensic applications. Clin. Pharmacokinet. 2003, 42, 1-31.
33. Holford, N.H.G. Clinical pharmacokinetics of ethanol. Clin. Pharmacokinet. 1987, 13, 273-292.
34. Zakhari, S. Overview: How is alcohol metabolized by the body? Alcohol Res. Health. 2006, 29, 245-254.
35. Agarwal, D.P. Genetic polymorphisms of alcohol metabolizing enzymes. Pathol. Biol. 2001, 49, 703-709.
36. Gemma, S.; Vichi, S.; Testai, E. Individual susceptibility and alcohol effects: Biochemical and genetic aspects. Ann. Ist. Super. Sanita 2006, 42, 8-16.
37. Weiner, H. Subcellular localization of acetaldehyde oxidation on liver. Ann. NY Acad. Sci. 1987, 492, 25-34.
38. Klein, H.; Harmjanz, D. Effect of ethanol infusion on the ultrastructure of human myocardium. Postgrad. Med. J. 1975, 51, 325-329.
39. Regan, T.J. Alcohol and the cardiovascular system. JAMA 1990, 264, 377-381.
40. Pachinger, O.; Mao, J.; Fauvel, J.-M.; Bing, R.J. Mitochondrial function and excitation-contraction coupling in the development of alcoholic cardiomypathy. In Recent Advances in Studies on Cardiac Structure and Metabolism; Fleckstein, A., Dhalla, N.S., Eds.; University Park Press: Baltimore, MD, USA, 1975; Volume 5, pp. 423-429.
41. Albano, E. Free radicals and alcohol-induced liver injury. In Ethanol and the Liver; Sherman, V.R., Watson, R.R., Eds.; Taylor and Francis: London, UK, 2002; pp. 153-190.
42. Robin, M.A.; Sauvage, I.; Grandperret, T.; Descatoire, V.; Pessayre, D.; Fromenty, B. Ethanol increases mitochondrial cytochrome P450 2E1 in mouse liver and rat hepatocytes. FEBS Lett. 2005, 579, 6895-6902.
43. Cederbaum, A.I. Microsomal generation of reactive oxygen species and their possible role in alcohol hepatoxicity. Alcohol Alcohol. 1991, Suppl 1, 291-296.
44. Adam-Vizi, V. Production of reactive oxygen species in brain mitochondria: Contribution by electron transport chain and non-electron transport chain sources. Antioxid. Redox Signal 2005, 7, 1140-1149.
45. Ronis, M.J.J.; Lindros, K.O.; Ingelman-Sundberg, M. The CYP2E family. In Cytochromes P450: Metabolic and Toxicological Aspects; Ioannides, C., Ed.; CRC Press: Boca Raton, FL, USA, 1996; pp. 211-239.
46. Liangpunsakul, S.; Kolwankar, D.; Pinto, A.; Gorski, C.J.; Hall, S.D.; Chalasani, N. Activity of CYP2E1 and CYP3A enzymes in adults with moderate alcohol consumption: A comparison with nonalcoholics. Hepatology 2005, 41, 1144-1150.
47. Albano, E. Alcohol, oxidative stress and free radical damage. Proc. Nutr. Soc. 2006, 65, 278-290.
48. Bailey, S.M.; Pietsch, E.C.; Cunningham, C.C. Ethanol stimulates the production of reactive oxygen species at mitochondrial complexes I and III. Free Radic. Biol. Med. 1999, 27, 891-900.
49. Cunningham, C.C.; Coleman, W.B.; Spach, P.I. The effects of chronic ethanol consumption on hepatic mitochondrial energy metabolism. Alcohol Alcohol. 1990, 25, 127-136.
50. Bailey, S.M.; Cunningham, C.C. Effect of dietary fat on chronic ethanol-induced oxidative stress in hepatocytes. Alcohol Clin. Exp. Res. 1999, 23, 1210-1218.
51. Bailey, S.M. A review of the role of reactive oxygen and nitrogen species in alcohol-induced mitochondrial energy metabolism. Free Radic. Res. 2003, 37, 585-596.
52. Mantena, S.K.; King, A.L.; Andringa, K.K.; Landar, A.; Darley-Usmar, V.; Bailey, S.M. Novel interactions of mitochondria and reactive oxygen/nitrogen species in alcohol mediated liver disease. World J. Gastroenterol. 2007, 13, 4967-4973.
53. Hoek, J.B.; Cahill, A.; Pastorino, J.G. Alcohol and mitochondria: A dysfunctional relationship. Gastroenterology 2002, 122, 2049-2063.
54. Coleman, W.B.; Cunningham, C.C. Effect of chronic ethanol consumption on hepatic mitochondrial transcription and translation. Biochim. Biophys. Acta 1991, 1058, 178-186.
55. Venkatraman, A.; Landar, A.; Davis, A.J.; Chamlee, L.; Sanderson, T.; Kim, H.; Page, G.; Pompilius, M.; Ballinger, S.; Darley-Usmar, V.; Bailey, S.M. Modification of the mitochondrial proteome in response to the stress of ethanol-dependent hepatotoxicity. J. Biol. Chem. 2004, 279, 22092-22101.
56. Bailey, S.M.; Robinson, G.; Pinner, A.; Chamlee, L.; Ulasova, E.; Pompilius, M.; Page, G.P.; Chhieng, D.; Jhala, N.; Landar, A.; Kharbanda, K.K.; Ballinger, S.; Darley-Usmar, V. S-adenosylmethionine prevents chronic alcohol-induced mitochondrial dysfunction in the rat liver. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 291, G857-G867.
57. Radi, R.; Cassina, A.; Hodara, R.; Quijano, C.; Castro, L. Peroxynitrite reactions and formation in mitocondria. Free Radic. Biol. Med. 2002, 33, 1451-1464.
58. Brookes, P.S.; Kraus, D.W.; Shiva, S.; Doeller, J.E.; Barone, M.C.; Patel, R.P.; Lancaster, J.R. Jr.; Darley-Usmar, V. Control of mitochondrial respiration by NO., effects of low oxygen and respiratory state. J. Biol. Chem. 2003, 278, 31603-31609.
59. Moon, K.H.; Hood, B.L.; Kim, B.J.; Hardwick, J.P.; Conrads, T.P.; Veenstra, T.D.; Song, B.J. Inactivation of oxidized and S-nitrosylated mitochondrial proteins in alcoholic fatty liver of rats. Hepatology 2006, 44, 1218-1230.
60. Matsuhashi, T.; Karbowski, M.; Liu, X.; Usukura, J.; Wozniak, M.; Wakabayashi, T. Complete suppression of ethanol-induced formation of megamitochondria by 4-hydroxy-2,2,6,6,-tetramethyl-piperidine-1-oxyl (4-OH-TEMPO). Free Radic. Biol. Med. 1998, 24, 139-147.
61. Meager, E.A.; Barry, O.P.; Burke, A.; Lucey, M.R.; Lawson, J.A.; Rokach, J.; FitzGerald, G.A. Alcohol-induced generation of lipid peroxidation products in humans. J. Clin. Invest. 1999, 104, 805-813.
62. Niemela, O.; Parkkila, S.; Yla-Herttuala, S.; Halsted, C.; Witztum, J.L.; Lanca, A.; Israel, Y. Covalent protein adducts in the liver as a result of ethanol metabolism and lipid peroxidation. Lab. Invest. 1994, 70, 537-546.
63. Slater, T.F. Free-radical mechanisms in tissue injury. Biochem. J. 1984, 222, 1-15.
64. Cortes-Rojo, C.; Calderon-Cortes, E.; Clemente-Guerrero, M.; Estrada-Villagomez, M.; Manzo-Avalos, S.; Mejia-Zepeda, R.; Boldogh, I.; Saavedra-Molina, A. Elucidation of the effects of lipoperoxidation on the mitochondrial electron transport chain using yeast mitochondria with manipulated fatty acid content. J. Bioenerg. Biomembr. 2009, 41, 15-28.
65. Fukumura, A.; Tsutsumi, M.; Tsuchishima, M.; Takase, S. Correlation between adenosine triphosphate content and apoptosis in liver of rats treated with alcohol. Alcohol Clin. Exp. Res. 2003, 27, 12S-15S.
66. Mansouri, A.; Fromenty, B.; Berson, A.; Robin, M.A.; Grimbert, S.; Beaugrand, M.; Erlinger, S.; Pessayre, D. Multiple hepatic mitochondrial DNA deletions suggest premature oxidative aging in alcoholic patients. J. Hepatol. 1997, 27, 96-102.
67. Tsuchishima, M.; Tsutsumi, M.; Shiroeda, H.; Yano, H.; Ueshima, Y.; Shimanaka, K.; Takase, S. Study of mitochondrial DNA deletion in alcoholics. Alcohol Clin. Exp. Res. 2000, 24, 12S-15S.
68. Von Wurmb-Schwark, N.; Ringleb, A.; Schwark, T.; Broese, T.; Weirich, S.; Schlaefke, D.; Wegener, R.; Oehmichen, M. The effect of chronic alcohol consumption on mitochondrial DNA mutagenesis in human blood. Mutat. Res. 2008, 637, 73-79.
69. Hirano, T.; Kaplowitz, N.; Kamimura, T.; Tsukamoto, H.; Fernandez-Checa, J.C. Hepatic mitocondrial GSH depletion and progression of experimental alcoholic liver disease in rats. Hepatology 1992, 16, 1423-1428.
70. Fernandez-Checa, J.C.; Kaplowitz, N. Hepatic mitochondrial glutathione: Transport and role in disease and toxicity. Toxicol. App. Pharmacol. 2005, 204, 263-273.
71. Rouach, H.; Fattaccioli, V.; Gentil, M.; French, S.W.; Morimoto, M.; Nordmann, R. Effect of chronic ethanol feeding on lipid peroxidation and protein oxidation in relation to liver pathology. Hepatology 1997, 25, 351-355.
72. Kowaltowski, A.J.; Castillo, R.F.; Vercesi, A.F. Mitochondrial permeability transition and oxidative stress. FEBS Lett. 2001, 495, 12-15.
73. Cortes-Rojo, C.; Clemente-Guerrero, M.; Saavedra-Molina, A. Effects of D-amino acids on lipoperoxidation in rat liver and kidney mitochondria. Amino Acids 2006, 32, 31-37.
74. Kim, J.S.; He, L.; Lemasters, J.J. Mitochondrial permeability transition: A common pathway to necrosis and apoptosis. Biochem. Biophys. Res. Commun. 2003, 304, 463-470.
75. Kim, W.H.; Hong, F.; Jaruga, B.; Zhang, Z.S.; Fan, S.J.; Liang, T.J.; Gao, B. Hepatitis B virus X protein sensitizes primary mouse hepatocytes to ethanol- and TNF-alpha-induced apoptosis by a caspase-3-dependent mechanism. Cell Mol. Immunol. 2005, 2, 40-48.
76. Urbano-Marquez, A.; Fernandez-Sola, J. Effects of alcohol on skeletal and cardiac muscle. Muscle Nerve 2004, 30, 689-707.
77. Capasso, J.M.; Li, P.; Guideri, G.; Malhotra, A.; Cortese, R.; Anversa, P. Myocardial mechanical, biochemical, and structural alterations induced by chronic ethanol ingestion in rats. Circ. Res. 1992, 71, 346-356.
78. Perfilova, V.N.; Ostrovskii, O.V.; Verovskii, V.E.; Popova, T.A.; Lebedeva, S.A.; Dib, H. Effect of citrocard on functional activity of cardiomyocyte mitochondria during chronic alcohol intoxication. Bull. Exp. Biol. Med. 2007, 143, 341-343.
79. Montgomery, R.I.; Coleman, W.B.; Eble, K.S.; Cunningham, C.C. Ethanol-elicited alterations in the oligomycin sensitivity and structural stability of the mitochondrial F0.F1 ATPase. J. Biol. Chem. 1987, 262, 13285-13289.
80. Usha, R.; Pendurthi, J.; Todd, W.; Vijya, M. Resveratrol a polyphenolic compound found in wine inhibits tissue factor expression in vascular cells. A possible mechanism for the cardiovascular benefits associated with moderate consumption of wine. Arterioscler. Thromb. Vasc. Biol. 1999, 19, 419-426.
81. Pace-Asciak, C.R.; Hahn, S.; Diamandis, E.P.; Soleas, G.; Goldberg, D.M. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications for protection against coronary heart disease. Clin. Chim. Acta 1995, 235, 207-219.
82. Bertelli, A.A.E.; Giovannini, L.; Giannessi, D.; Migliori, M.; Bernini, W.; Fregoni, M.; Bertelli, A. Antiplatelet activity of synthetic and natural resveratrol in red wine. Int. J. Tiss. Reac. 1995, 17, 1-3.
83. Baur, J.A.; Sinclair, D.A. Therapeutic potential of resveratrol: The in vivo evidence. Nat. Rev. Drug Discov. 2006, 5, 493-506.
84. Howitz, K.T.; Bitterman, K.J.; Cohen, H.Y.; Lamming, D.W.; Lavu, S.; Wood, J.G.; Zipkin, R.E.; Chung, P.; Kisielewski, A.; Zhang, L.L.; Scherer, B.; Sinclair, D.A. Small molecule activators of sirtuins extended Saccharomyces cerevisiae lifespan. Nature 2003, 425, 191-196
85. Belguendouz, L.; Fremont, L.; Gozzelino, M.T. Interaction of transresveratrol with plasma lipoproteins. Biochem. Pharmacol. 1998, 55, 811-816.
86. Das, S.; Falchi, M.; Bertelli, A.; Maulik, N.; Das, D.K. Attenuation of ischemia/reperfusion injury in rats by the anti-inflammatory action of resveratrol. Arzneimittelforschung 2006, 56, 700-706.
87. Das, S.; Alagappan, V.K.; Bagchi, D.; Sharma, H.S.; Maulik, N.; Das, D.K. Coordinated induction of iNOS-VEGF-KDR-eNOS after resveratrol consumption: A potential mechanism for resveratrol preconditioning of the heart. Vascul. Pharmacol. 2005, 42, 281-289.
88. Hattori, R.; Otani, H.; Maulik, N.; Das, D.K. Pharmacological preconditioning with resveratrol: Role of nitric oxide. Am. J. Physiol. 2002, 282, H1988-H1995.
89. Li, H.L.; Wang, A.B.; Huang, Y.; Liu, D.P.; Wei, C.; Williams, G.M.; Zhang, C.N.; Liu, G.; Liu, Y.Q.; Hao, D.L.; Hui, R.T.; Lin, M.; Liang, C.C. Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways. Free Radic. Biol. Med. 2005, 38, 243-257.
90. Kaga, S.; Zhan, L.; Matsumoto, M.; Maulik, N. Resveratrol enhances neovascularization in the infarcted rat myocardium through the induction of thioredoxin-1, heme oxygenase-1 and vascular endothelial growth factor. J. Mol. Cell Cardiol. 2005, 39, 813-822.
91. Zhang, Y.; Liu, Y.; Wang, T.; Li, H.; Wang, Z.; Yang, B. Resveratrol, a natural ingredient of grape skin: Antiarrhyhtmic efficacy and ionic mechanisms. Biochem. Biophys. Res. Commun. 2006, 340, 1192-1199.
92. Wang, S.; Wang, X.; Yan, J.; Xie, X.; Fan, F.; Zhou, X.; Han, L.; Chen, J. Resveratrol inhibits proliferation of cultured rat cardiac fibroblasts: Correlated with NO-cGMP signaling pathway. Eur. J. Pharmacol. 2007, 567, 26-35.
93. Hayek, T.; Fuhrman, B.; Vaya, J.; Rosenblat, M.; Belinky, P.; Coleman, R.; Elis, A.; Aviram, M. Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arterioscler. Thromb. Vasc. Biol. 1997, 17, 2744-2752.
94. Rosenkranz, S.; Knirel, D.; Dietrich, H.; Flesch, M.; Erdmann, E.; Bohm, M. Inhibition of the PDGF receptor by red wine flavonoids provides a molecular explanation for the ''French paradox''. FASEB J. 2002, 16, 1958-1960.
95. Halder, U.G.; Roos, T.U.; Kontaridis, M.I.; Neel, B.G.; Sorescu, D.; Griedling, K.K.; Vollmar, A.M.; Dirsch, V.M. Resveratrol inhibits angiotensin II and epidermal growth factor-mediated Akt activation: Role of Gab1 and Shp2. Mol. Pharmacol. 2005, 68, 41-48.
96. Karatzi, K.N.; Papamichael, C.M.; Karatzis, E.N.; Papaioannou, T.G.; Aznaouridis, K.A.; Katsichti, P.P.; Stamatelopoulos, K.S.; Zampelas, A.; Lekakis, J.P.; Mavrikakis, M.E. Red wine acutely induces favorable effects on wave reflections and central pressures in coronary artery diseases patients. Am. J. Hypertens. 2005, 18, 1161-1167.
97. Baur, J.A.; Pearson, K.J.; Price, N.L.; Jamieson, H.A.; Lerin, C.; Kalra, A.; Prabhu, V.V.; Allard, J.S.; Lopez-Lluch, G.; Lewis, K.; Pistell, P.J.; Poosala, S.; Becker, K.G.; Boss, O.; Gwinn, D.; Wang, M.; Ramaswamy, S.; Fishbein, K.W.; Spencer, R.G.; Lakatta, E.G.; Le Couteur, D.; Shaw, R.J.; Navas, P.; Puigserver, P.; Ingram, D.K.; de Cabo, R.; Sinclair, D.A. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444, 337-342.
98. Penumathsa, S.V.; Thirunavukkarasu, M.; Koneru, S.; Juhasz, B.; Zhan, L.; Pant, R.; Menon, V.P.; Otani, H.; Maulik, N. Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat. J. Mol. Cell Cardiol. 2007, 42, 508-516.
99. Penumathsa, S.V.; Maulik, N. Resveratrol: A promising agent in promoting cardioprotection against coronary heart disease. Can. J. Physiol. Pharmacol. 2009, 87, 275-286.
100. Wagner, T.M.; Mullally, J.E.; Fitzpatrick, F.A. Reactive lipid species from cyclooxygenase-2 inactivate tumor suppressor LKB1/STK11: Cyclopentenone prostaglandins and 4-hydroxy-2-nonenal covalently modify and inhibits the AMP kinase kinase that modulates cellular energy homeostasis and protein translation. J. Biol. Chem. 2006, 281, 2598-2604.
101. Pan, J.S.; He, S.Z.; Xu, H.Z.; Zhan, X.J.; Yang, X.N.; Xiao, H.M.; Shi, H.X. Oxidative stress disturbs energy metabolism of mitochondria in ethanol-induced gastric mucosa injury. World J. Gastroenterol. 2008, 14, 5857-5867.
102. Yin, G.Y.; Zhang, W.N.; Shen, X.J.; Chen, Y.; He, X.F. Ultrastructure and molecular biological changes of chronic gastritis, gastric cancer and gastric precancerous lesions: A comparative study. World J. Gastroenterol. 2003, 9, 851-857.
103. Hoek, J.B.; Cahill, A.; Pastorino, J.G. Alcohol and mitochondria: A dysfunctional relationship. Gastroenterology 2002, 122, 2049-2063.
104. Rong, Q.; Utevskaya, O.; Ramilo, M.; Chow, D.C.; Forte, J.G. Nucleotide metabolism by gastric glands and H(+)-k(+)-ATPase-enriched membranes. Am. J. Physiol. 1998, 274, G103-G110.
105. Giannessi, F.; Giambelluca, M.A.; Grasso, L.; Scavuzzo, M.C.; Ruffoli, R. Curcumin protects Leydig cells of mice from damage induced by chronic alcohol administration. Med. Sci. Monit. 2008, 14, 237-242.
106. Wakabayashi, T. Megamitochondria formation-physiology and pathology. J. Cell Mol. Med. 2002, 6, 497-538.
107. Dey, A.; Cederbaum, A.I. Alcohol and oxidative liver injury. Hepatology 2006, 43, S63-S74.
108. Mills, S.J.; Harrison, S.H. Comparison of the natural history of alcoholic and nonalcoholic fatty liver disease. Curr. Gastroenterol. Reports. 2010, 7, 32-36.
109. Stewart, S.; Jones, D.; Day, C.P. Alcoholic liver disease: New insights into mechanisms and preventative strategies. Trends Mol. Med. 2001, 7, 408-413.
110. Morgan, T.R.; Mandayam, S.; Jamal, M.M. Alcohol and hepatocellular carcinoma. Gastroenterology 2004, 127, S87-96.
111. Miranda-Mendez, A.; Lugo-Baruqui, A.; Armendariz-Borunda, J. Molecular basis and current treatment for alcoholic liver disease. Int. J. Environ. Res. Public Health 2010, 7, 1872-1888.
112. Malhi, H.; Gores, G.J. Cellular and molecular mechanisms of liver injury. Gastroenterology 2008, 134, 1641-1654.
113. Song, B.J.; Moon, K.H.; Olsson, N.U.; Salem, N. Jr. Prevention of alcoholic fatty liver and mitochondrial dysfunction in the rat by long-chain polyunsaturated fatty acids. J. Hepatol. 2008, 49, 262-273.
114. Friedman, S.L. Molecular regulation of hepatic fibrosis, and integrated cellular response to tissue injury. J. Biol. Chem. 2000, 275, 2247-2250.
115. Bronchal, S.; Nain, C.K.; Prasad, K.K.; Nada, R.; Sharma, A.K.; Sinha, S.K.; Singh, K. Functional and morphological alterations in small intestine mucosa of chronic alcoholics. J. Gastroenterol. Hepatol. 2008, 23, e43-e48.
116. Kravos, M.; Malesic, I. Kinetics and isoforms of serum glutamate dehydrogenase in alcoholics. Alcohol Alcohol. 2008, 43, 281-286.
117. Lakshmi, D.S.; Anuradha, C.V. Mitochondrial damage, cytotoxicity and apoptosis in iron-potentiated alcoholic liver fibrosis: Amelioration by taurine. Amino Acids 2010, 38, 869-879.
118. Sastre, J.; Serviddio, G.; Pereda, J.; Minana, J.B.; Arduini, A.; Vendemiale, G.; Poli, G.; Pallardo, F.V.; Vina, J. Mitochondrial function in liver disease. Front. Biosci. 2007, 12, 1200-1209.
119. Hajnoczky, G.; Buzas, C.J.; Pacher, P.; Hoek, J.B.; Rubin, E. Alcohol and mitochondria in cardiac apoptosis: Mechanisms and visualization. Alcohol Clin. Exp. Res. 2005, 29, 693-701.
120. White, A.M. What happened? Alcohol, memory blackouts, and the brain. Alcohol Res. Health 2003, 27, 186-196.
121. Davis, K.M.; Wu, J.Y. Role of glutamatergic and GABAergic systems in alcoholism. J. Biomed. Sci. 2001, 8, 7-19.
122. Koch-Weser, J.; Sellers, E.M.; Kalent, H.L. Alcohol intoxication and withdrawal. N. Engl. J. Med. 1976, 294, 757-762.
123. Kosten, T.R.; O'Connor, P.G. Management of drug and alcohol withdrawal. N. Engl. J. Med. 2003, 348, 1786-1795.
124. Brust, J.C.M. Ethanol and cognition: Indirect effects, neurotoxicity and neuroprotection: A review. Int. J. Environ. Res. Public Health 2010, 7, 1540-1557.
125. Obenier, J.A.; Bouldin, T.W.; Crews, F.T. Binge ethanol exposure in adult rats causes necrotic cell death. Alcohol Clin. Exp. Res. 2002, 26, 547-557.
126. Silvers, J.M.; Tokunaga, S.; Berry, R.B.; White, A.M.; Matthews, D.B. Impairment in spatial learning and memory: Ethanol, allopregnanolone, and the hippocampus. Brain Res. Brain Res. Rev. 2003, 43, 275-284.
127. Grant, I. Alcohol and the brain: Neuropsychological correlates. J. Consult. Clin. Psychol. 1987, 55, 310-324.
128. Israel, Y.; Kalant, H. Effect of ethanol on the transport of sodium in frog skin. Nature 1963, 200, 476-478.
129. Blum, K.; Noble, E.P.; Sheridan, P.J.; Montgomery, A.; Ritchie, T.; Jagadeesawaran, P.; Nogami, H.; Briggs, A.H.; Cohn, J.B. Allelic association of human dopamine D2 and Gaba receptor gene in alcoholism. JAMA 1990, 263, 2055-2060.
130. Kluge, H.; Neumann, J.; Seidel, K. Biochemical mechanisms for the effect of alcohol on the brain. Psychiatr. Neurol. Med. Psychol. (Leipz) 1979, 31, 65-73.
131. Kharchenko, N.K. Dopamine content in blood and activity of alcohol-transforming enzymes in alcoholism. Ukr. Biokhim. Zh. 1997, 69, 87-92.
132. Smith, A.A. Interaction of biogenic amines with ethanol. Adv. Exp. Med. Biol. 1975, 56, 265-275.
133. Weiner, H. Relationship between 3,4-dihydroxyphenylacetaldehyde levels and tetrahydropapaveroline formation. Alcohol Clin. Exp. Res. 1978, 2, 127-131.
134. Haorah, J.; Ramírez, S.H.; Floreani, N.; Gorantla, S.; Morsey, B.; Persidsky, Y. Mechanism of alcohol-induced stress and neuronal injury. Free Radic. Biol. Med. 2008, 45, 1542-1550.
135. Mansouri, A.; Demeilliers, C.; Amsellen, S.; Pessayre, D.; Fromenty, B. Acute ethanol administration oxidatively damages and depletes mitochondrial DNA in mouse liver, brain, heart, and skeletal muscles: Protective effects of antioxidants. J. Pharmacol. Exp. Ther. 2001, 298, 737-743.
136. Jung, M.E.; Agarwal, R.; Simpkins, J.W. Ethanol withdrawal posttranslationally decreases the activity of cytochrome c oxidase in an estrogen reversible manner. Neurosci. Lett. 2007, 41, 160-164.
137. Jung, M.E.; Simpkins, J.W.; Wilson, A.M.; Downey, H.F.; Mallet, R.T. Intermittent hypoxia conditioning prevents behavioral deficit and brain oxidative stress in ethanol-withdrawn rats. J. Appl. Physiol. 2008, 105, 510-517.
138. Lee do, Y.; Lee, K.S.; Lee, H.J.; Jung, H.Y.; Lee, J.Y.; Lee, S.H.; Youn, Y.C.; Seo, K.M.; Lee, J.H.; Lee, W.B.; Kim, S.S. Alcohol enhances Abeta42-induced neuronal cell death through mitochondrial dysfunction. FEBS Lett. 2008, 582, 4185-4190.
139. Streissguth, A.P.; Landersman-Dwyer, S.; Martin, J.C.; Smith, D.W. Teratogenic effects of alcohol in humans and laboratory animals. Science 1980, 209, 353-361.
140. Clarren, S.K.; Alvord, E.C.; Sumi, S.M.; Streissguth, A.P.; Smith, D.W. Brain malformations related to prenatal exposure to ethanol. J. Pediatr. 1978, 92, 64-67.
141. Riikonen, R.S.; Nokelainen, P.; Valkonen, K.; Kolehmainen, A.I.; Kumpulainen, K.I.; Könönen, M.; Vanninen, R.L.; Kuikka, J.T. Deep serotonergic and dopaminergic structures in fetal alcoholic syndrome: A study with nor-beta-CIT-single-photon emission computed tomography and magnetic resonance imaging volumetry. Biol. Psychiatry 2005, 57, 1565-1572.
142. Druse, M.J.; Tajuddin, N.F.; Gillespie, R.A.; Le, P. The effects of ethanol and the serotonin(1A) agonist ipsapirone on the expression of the serotonin(1A) receptor and several antiapoptotic proteins in fetal rhombencephalic neurons. Brain Res. 2006, 1092, 79-86.
143. Sari, Y.; Powrozek, T.; Zhou, F.C. Alcohol deters the outgrowth of serotonergic neurons at midgestation. J. Biomed. Sci. 2001, 8, 119-125.
144. Mayordomo, F.: Renau-Piqueras, J.; Megias, L.; Guerri, C.; Iborra, F.J.; Azorin, I.; Ledig, M. Cytochemical and stereological analysis of rat cortical astrocytes during development in primary culture. Effect of prenatal exposure to ethanol. Int. J. Dev. Biol. 1992, 36, 311-321.
145. Devi, B.G.; Henderson, G.I.; Frosto, T.A.; Schenker, S. Effect of ethanol on rat fetal hepatocytes: Studies on cell replication, lipid peroxidation and glutathione. Hepatology 1993, 18, 648-659.
146. Sanchis, R.; Guerri, C. Alcohol-metabolizing enzymes in placenta and fetal liver: Effect of chronic ethanol intake. Alcohol Clin. Exp. Res. 1986, 10, 39-44.
147. Maheshwari, R.K.; Singh, A.K.; Gaddipati, J.; Srimal, R.C. Multiple biological activities of curcumin: A short review. Life Sci. 2006, 78, 2081-2087.
148. Priyadarsini, K.I.; Maity, D.K.; Naik, G.H.; Kumar, M.S.; Unnikrishnan, M.K.; Satav, J.G.; Mohan, H. Role of phenolic O-H and methylene hydrogen on the free radical reactions and antioxidant activity of curcumin. Free Radic. Biol. Med. 2003, 35, 475-484.
149. Churchill, E.N.; Disatnik, M.H.; Mochly-Rosen, D. Time-dependent and ethanol-induced cardiac protection from ischemia mediated by mitochondrial translocation of varepsilon PKC and activation of aldehyde dehydrogenase2. J. Mol. Cell Cardiol. 2009, 46, 278-284.
150. Cannon, C.P.; Braunwald, E.; McCabe, C.H.; Rader, D.J.; Rouleau, J.L.; Belder, R.; Joyal, S.V.; Hill, K.A.; Skene, A.M. Pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 investigators. N. Engl. J. Med. 2004, 350, 1495-1504.
151. Blake, G.J.; Ridker, P.M. Novel clinical markers of vascular wall inflammation. Circulation Res. 2001, 89, 763-771.
152. Clarke, R.; Daly, L.; Robinson, K.; Naughten, E.; Cahalane, S.; Fowler, B.; Graham, I. Hyperhomocysteinemia: An independent risk factor for vascular disease. N. Engl. J. Med. 1991, 324, 1149-1155.
153. Brisdelli, F.; D'Andrea, G.; Bozzi, A. Resveratrol: A natural polyphenol with multiple chemopreventive properties. Curr. Drug Metab. 2009, 10, 530-46.
154. Cheng, T.H.; Liu, J.C.; Lin, H.; Shih, N.L.; Chen, Y.L.; Huang, M.T.; Chan, P.; Cheng, C.F.; Chen, J.J. Inhibitory effect of resveratrol on angiotensin II-induced cardiomyocyte hypertrophy. Naunyn Schmiedebergs Arch. Pharmacol. 2004, 369, 239-244.
155. Chan, A.Y.; Dolinsky, V.W.; Soltys, C.L.; Viollet, B.; Baksh, S.; Light, P.E.; Dyck, J.R. Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt. J. Biol. Chem. 2008, 283, 24194-24201.
156. Serafini, M.; Maiani, G.; Ferro-Luzzi, A. Alcohol-free red wine enhances plasma antioxidant capacity in humans. J. Nutr. 1998, 128, 1003-1007.
157. Opie, L.H.; Lecour, S. The red wine hypothesis: From concepts to protective signalling molecules. Eur Heart J. 2007, 28, 1683-1693.
158. Hung, L.M.; Chen, J.K.; Lee, R.S.; Liang, H.C.; Su, M.J. Beneficial effects of astringinin, a resveratrol analogue, on the ischemia and reperfusion damage in rat heart. Free Radic. Biol. Med. 2001, 30, 877-883.
159. Fauconneau, B.; Waffo-Teguo, P.; Huguet, F.; Barrier, L.; Decendit, A.; Merillon, J.M. Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests. Life Sci. 1997, 61, 2103-2110.
160. El-Assal, O.; Hong, F.; Kim, W-H.; Radaeva, S.; Gao, B. IL-6 deficient mice are susceptible to ethanol-induced hepatic steatosis: IL-6 protects against ethanol-induced oxidative stress and mitochondrial permeability transition in the liver. Cell Mol. Immunol. 2004, 1, 205-211.
161. Hong, F.; Kim, W.H.; Tian, Z.; Jaruga, B.; Ishac, E.; Shen, X.; Gao, B. Elevated interleukin-6 during ethanol consumption acts as a potential endogenous protective cytokine against ethanol-induced apoptosis in the liver: Involvement of induction of Bcl-2 and Bcl-x(L) proteins. Oncogene 2002, 21, 32-43.
162. Lowe, E.D.; Gao, G.Y.; Johnson, L.N.; Keung, W.M. Structure of didzin, a naturally occurring anti-alcohol-addiction agent, in complex with human mitochondrial aldehyde dehydrogenase. J. Med. Chem. 2008, 51, 4482-4487.
163. Kim, Y.C.; Jung, Y.S.; Kim, S.K. Effect of betaine supplementation on changes in hepatic metabolism of sulfur-containing amino acids and experimental cholestasis induced by alphanaphthylisothiocyanate. Food Chem. Toxicol. 2005, 43, 663-670.
164. Craig, S.A. Betaine in human nutrition. Am. J. Clin. Nutr. 2004, 80, 539-549.
165. Zhang, P.; Gong, Z.J.; Wang, L.W.; Sun, X.M.; Zhou, X.R. Effects of Betaine on hyperhomocysteinemia and lipid peroxidation in rats with ethanol-induced liver injury. Zhongxiyi Jiehe Ganbing Zazhi 2006, 16, 30-32.
166. Ji, C.; Shinohara, M.; Vance, D.; Than, T.A.; Ookhtens, M.; Chan, C.; Kaplowitz, N. Effect of transgenic extrahepatic expression of betaine-homocysteine methyltransferase on alcohol or homocysteine-induced fatty liver. Alcohol Clin. Exp. Res. 2008, 32, 1049-1058.
167. Cantoni, G.L. Activation of methionine for transmethylation. J. Biol. Chem. 1951, 189, 745-754.
168. Mato, J.M.; Alvarez, L.; Ortiz, P.; Pajares, M.A. S-adenosylmethionine synthesis: Molecular mechanisms and clinical implications. Pharmacol. Ther. 1997, 73, 265-280.
169. Santamaria, E.; Avila, M.A.; Latasa, M.U.; Rubio, A.; Martin-Duce, A.; Lu, S.C.; Mato, J.M.; Corrales, F.J. Functional proteomics of nonalcoholic steatohepatitis: Mitochondrial proteins as targets of S-adenosylmethionine. Proc. Natl. Acad. Sci. USA. 2003, 100, 3065-3070.
170. Bailey, S.M.; Robinson, G.; Pinner, A.; Chamlee, L.; Ulasova, E.; Pompilius, M.; Page, G.P.; Chhieng, D.; Jhala, N.; Landar, A.; Kharbanda, K.K.; Ballinger, S.; Darley-Usmar, V. S-adenosylmethionine prevents chronic alcohol-induced mitochondrial dysfunction in the rat liver. Am. J. Gastrointest. Liver Physiol. 2006, 291, G857-G867.